Thought Leadership
Email Page
US FDA Postpones Celltrion's Remicade Biosimilar Review Meeting
February 27, 2015
Gareth MacDonald
BioPharma Reporter.com

Axinn Counsel Stacie Ropka was quoted in the online BioPharma Reporter article, "US FDA Postpones Celltrion's Remicade Biosimilar Review Meeting." 

Click here to access the article. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.